Bio Heal Boh

CJ Corp. announced it will strengthen its research and development (R&D) efforts in the bio and healthcare sectors. CJ CheilJedang Corp. ...

BJ Biochem Inc. is a startup that develops various differentiated materials in the preservatives, disinfectants and surface active agent (surfactant...

Peak Bio Co., a South Korean biopharmaceutical company, is debuting on the Nasdaq through a merger with US blank cheque company Ignyte Acquisition C...

US private equity giant The Carlyle Group and South Korean energy-to-retail conglomerate GS Group will acquire Medit Corp., the world’s third-...

South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...

South Korea’s top mobile carrier SK Telecom Co. is expanding its business portfolio with quantum technology, even into industries that are unr...

President Joe Biden’s plan to support the US biomanufacturing infrastructure aimed at containing China’s clout is posing a threat to Sou...

South Korea’s diagnostic devices supplier Precision Biosensor Inc. has signed an export contract with Italian medical device company Borden Ch...

Hyosung TNC Corp., a South Korean textile and yarn maker, is showcasing the world’s first commercialized plant-based spandex at an internation...

Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...

South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...

SK Discovery Co., an intermediate holding company of South Korea’s third-largest conglomerate SK Group, will take charge of the entire biotech...

Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...

South Korean biotech company L&C Bio, which specializes in tissue regeneration treatment, is poised to ramp up its expansion into the Chinese ma...

Lotte Group is preparing to kickstart its biopharmaceutical business as a contract development and manufacturing company (CDMO) by building a new pl...

SV Investment, a South Korean venture capital and private equity firm, is looking to launch a $100 million bio fund in the US as a growing number of...

"It's not a matter of numbers, but a matter of do or die for us."This is the first public remark from Samsung Electronics Co. Vice Chairman and de f...

SK Group, South Korea’s second-largest conglomerate after Samsung, on Thursday announced a plan to invest 247 trillion won ($195 billion) in k...

South Korea’s Lotte Group will spend a total of 37 trillion won ($29 billion) on its businesses over the next five years, a chunk of which wil...

South Korea’s top conglomerate Samsung has unveiled a plan to invest 450 trillion won ($355 billion) over the next five years in strategic sec...

Hyundai Oilbank Co., a South Korean petroleum and refinery company, is slated to tap into the white biotechnology market. The company has selected w...

Public Officials Benefit Association (POBA) of South Korea will keep its focus on steady cash flow while strengthening profitability, its Chief Inve...

A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...

Scores of South Korean initial public offerings slated for the first half of this year have been delayed after the bourse operator carried out a lar...

Valuence Merger Corp. 1, a special purpose acquisition company (SPAC), led by South Korean fund managers, has debuted on the Nasdaq, targeting Asian...

Biopharmaceutical companies of South Korea are having a tough time fundraising of late. Bio ventures without specific public offering plans are pa...

Back in January 2017, SK Group Chairman Chey Tae-won emphasized the need for “deep change," in his New Year message and presented the phrase a...

South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...

CICC Capital, a private equity firm of China's largest investment bank China International Capital Corporation (CICC), will create funds with a comb...

SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...